Table 3 Actuarial survival rates related to +/- systemic therapy and tGTV volume
Parameters (n) | 3y-OAS | 3y-DFS | 3y-DMFS | 3y-LRC |
|---|---|---|---|---|
entire cohort (112) | 58% | 50% | 70% | 61% |
no systemic therapy (14) | 25% | 17% | 50% | 25% |
any systemic therapy (98) | 61% | 53% | 72% | 64% |
p-value | < 0.0001 | 0.01 | 0.1 (NS) | 0.04 |
< 130 cc (91) | 58% | 51% | 75% | 62% |
> 130 cc (21) | 30% | 38% | 40% | 40% |
p-value | 0.1 (NS) | 0.2(NS) | 0.001 | 0.05 |
no systemic therapy (14) | 25% | 17% | 50% | 25% |
any systemic therapy, > 130 cc (19) | 30% | 40% | 50% | 45% |
any systemic therapy, < 130 cc (79) | 63% | 55% | 78% | 76% |
p-value | 0.0001 | 0.03 | 0.01 | 0.04 |